Tandem Diabetes Care Inc (TNDM)
R&D Expenses
$46.93M
Quarterly · Period ending: · USD
TNDM R&D Expenses
Latest reported$46.93Mperiod ending
Latest reported$46.93Mperiod ending
TNDM Quarterly R&D Expenses ($2.11M → $46.93M)
Quarterly R&D Expenses
High-resolution chart · PNG
TNDM r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 46,930,000 | |
| 46,035,000 | |
| 46,066,000 | |
| 47,883,000 | |
| 48,118,000 | |
| 125,432,000 | |
| 52,200,000 | |
| 51,107,000 | |
| 49,326,000 | |
| 46,244,000 | |
| 42,604,000 | |
| 41,970,000 | |
| 42,933,000 | |
| 120,910,000 | |
| 35,608,000 | |
| 67,814,000 | |
| 33,571,000 | |
| 33,160,000 | |
| 29,492,000 | |
| 24,102,000 | |
| 20,499,000 | |
| 17,961,000 | |
| 17,376,000 | |
| 16,094,000 | |
| 15,987,000 | |
| 14,117,000 | |
| 12,567,000 | |
| 12,038,000 | |
| 11,204,000 | |
| 9,389,000 | |
| 8,797,000 | |
| 7,999,000 | |
| 6,456,000 | |
| 5,975,000 | |
| 5,751,000 | |
| 4,914,000 | |
| 4,866,000 | |
| 5,130,000 | |
| 4,344,000 | |
| 6,154,000 | |
| 4,142,000 | |
| 4,169,000 | |
| 4,121,000 | |
| 5,093,000 | |
| 3,873,000 | |
| 3,863,000 | |
| 3,922,000 | |
| 4,508,004 | |
| 3,698,000 | |
| 3,663,320 | |
| 3,346,382 | |
| 2,651,580 | |
| 2,758,761 | |
| 2,322,477 | |
| 1,989,279 | |
| 2,109,868 |